Vireo Growth (VREOF) Interest Coverage Ratio (QoQ) (2020 - 2026)
Vireo Growth (VREOF) Interest Coverage Ratio (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Vireo Growth | 482.88 Mn | 340.58 Mn | 95.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151.28% |
| Dec 31, 2025 | -2,328.48% |
| Sep 30, 2025 | 109.20% |
| Jun 30, 2025 | -112.56% |
| Mar 31, 2025 | 313.17% |
| Dec 31, 2024 | -123.60% |
| Sep 30, 2024 | 2,454.31% |
| Jun 30, 2024 | -91.39% |
| Mar 31, 2024 | -90.40% |
| Dec 31, 2023 | 234.27% |
| Sep 30, 2023 | 744.55% |
| Jun 30, 2023 | -7,592.67% |
| Mar 31, 2023 | -98.44% |
| Dec 31, 2022 | 390.38% |
| Sep 30, 2022 | -278.70% |
| Jun 30, 2022 | 108.83% |
| Mar 31, 2022 | 88.18% |
| Dec 31, 2021 | -11,197.98% |
| Sep 30, 2021 | 57.73% |
| Jun 30, 2021 | 39.09% |